Bristol Myers Squibb Receives U.S. FDA Approval of New State-of-the-Ar...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: September 21, 2023

Orion S.A. Declares Interim Quarterly Dividend • Church of the Highlands Opens New Huntsville Campus Location • Métis Citizens elect new president in first election for new Otipemisiwak Métis Government • Lieutenant General, U.S. Army (Retired) Francis M. Beaudette Named Ambassador at PenFed Foundation • Mattel Publishes Latest Citizenship Report Presenting 2022 Progress on ESG Strategy and Goals • Dominican President Addresses UN to Defend His Nation’s Measures Against Haiti’s Illegal Canal Construction Project • Pennsylvania American Water Reaches Agreement to Acquire Audubon Water Company • Métis Nation within Alberta Citizens elect new President and Citizens' Council, formally becoming the Otipemisiwak M&eacu • Revry and Discover Present The 8th Annual Queer X Awards on National Coming Out Day • Sean "Diddy" Combs Applauds Black Leaders' Commitment to Defending Democracy, Driving Corporate Diversity at Congressional Black • LeadingAge And Ziegler Release 20th Annual LeadingAge Ziegler LZ 200 Report • UNITE HERE Local 11: Laguna Cliffs Hospitality Workers Rally at UC Regents Meeting in Los Angeles • COSMOSS Partners With Chopra Foundation 'Never Alone' to Support Mental Health Awareness • Valent BioSciences Announces Construction of New Oregon Facility • Sen. Bernie Sanders Addresses Critical Shortage of Black Physicians at the NMA's Professional Development Series • QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA • Five Cities Join Sunstone Economic Development Challenge @ USC Price • TinySuperheroes Celebrates Its 10th Anniversary Outfitting Courageous Kids With Superhero Capes As They Battle Illnesses and Dis • Sendero Health Plans Names Sharon Alvis as Next Chief Executive • Young Travel & Cruises Educational Seminars Offer Upstate SC Travel Enthusiasts a Chance to Learn about Land, River and Sea

Bristol Myers Squibb Receives U.S. FDA Approval of New State-of-the-Art Cell Therapy Manufacturing Facility in Devens, Massachus

PRINCETON, N.J. , June 08 /Businesswire/ - $BMY announces U.S. Food and Drug Administration approval for commercial production of #CARTcelltherapy at their newest facility in Devens, Massachusetts, expanding #manufacturing footprint for long-term supply of the company’s cell therapy portfolio